Skip to content

Patient Experience and Acceptance of Horizontal Rotation

Nano-X: Patient Experience and Acceptance of Horizontal Rotation

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02995603
Acronym
Nano-X
Enrollment
43
Registered
2016-12-16
Start date
2019-12-14
Completion date
2025-12-31
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Radiotherapy, Rotation

Brief summary

Patients will complete validated psychometric questionnaires to quantify their experience of being rotated at different speeds using the Nano-X patient rotation system.

Detailed description

Study participants will be asked to attend the clinic on two separate occasions. Each session will last less than one hour. Patients will be asked to complete validated psychometric surveys assessing 1) their level of claustrophobia, 2) their level of anxiety and 3) their (baseline) motion sickness, before and after each session. They will then be rotated 3-4 times on the Nano-X patient rotation system, at varying speeds ranging from 6°/sec to 45°/sec. Each rotation will be designed to simulate a typical radiotherapy treatment; that is 9 angles, pausing for around 30 seconds at each angle. Straight after each rotation, patients will again complete the questionnaire assessing their anxiety levels and motion sickness.

Interventions

DEVICENano-X patient rotation

Patients are required to completed validated questionnaires to quantify their experience of horizontal rotation.

Sponsors

University of Sydney
Lead SponsorOTHER
Prince of Wales Hospital, Sydney
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. A diagnosis of cancer, any stage 2. ≥18 years of age 3. Eastern Cooperative Oncology Group (ECOG) status 0-2 4. Currently or previously being treated with radiotherapy 5. Any prior therapy allowed 6. Willing and able to comply with all study requirements 7. Must be able to read and complete questionnaires in English 8. Signed, written informed consent

Exclusion criteria

1. Pregnant women 2. Mentally impaired patients or patients for whom attaining informed consent would be difficult (including language barriers) 3. Severe vertigo or recent diagnosis of Benign Paroxysmal Positioning Vertigo

Design outcomes

Primary

MeasureTime frameDescription
Change in level of patient anxiety following rotation in the Nano-X Patient Rotation System1 hourComparison of mean scores of Short Form State/Trait Anxiety Inventory (STAI) Questionnaire outcomes before and after being rotated in the Nano-X Patient Rotation System
Change in level of patient motion sickness following rotation in the Nano-X Patient Rotation System1 hourComparison of mean scores of Fast Motion Sickness Test (FMS) Questionnaire outcomes before and after being rotated in the Nano-X Patient Rotation
Correlation between claustrophobia and the change in anxiety and motion sickness of patients following rotation in the Nano-X Patient Rotation System1 yearCorrelation between Claustrophobia Questionnaire (CLQ) scores prior to study participation on the anxiety and motion sickness results measured in Outcome 1 and Outcome 2

Countries

Australia

Contacts

STUDY_CHAIRPaul Keall, Prof

University of Sydney

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026